Best Seller Items
Hot
-44%
-41%
Hot
-45%
Headon HGH 4×10 IU
Original price was: ₹ 10,937.50.₹ 6,000.00Current price is: ₹ 6,000.00.Hot
-29%
-10%
Hot
-47%
Eutropin 4 Iu Inj
Original price was: ₹ 1,700.00.₹ 900.00Current price is: ₹ 900.00.-19%
-14%
Zomacton 12 IU Inj
Original price was: ₹ 3,260.00.₹ 2,800.00Current price is: ₹ 2,800.00.-40%
Featured Items
Hot
Hot
Hot
Hot
Hot
-55%
Hot
-29%
Hot
-45%
Headon HGH 4×10 IU
Original price was: ₹ 10,937.50.₹ 6,000.00Current price is: ₹ 6,000.00.Hot
-47%
Eutropin 4 Iu Inj
Original price was: ₹ 1,700.00.₹ 900.00Current price is: ₹ 900.00.Hot
-44%
-
-7%
Orencia 250Mg
Original price was: ₹ 26,990.00.₹ 25,000.00Current price is: ₹ 25,000.00.BRISTOL MYRES SQUIB
PACKING : 1 VIAL
GENERIC NAME : ABATACEPT
-
-10%
Xolair Lyvi 150Mg 2ML
Original price was: ₹ 32,590.00.₹ 29,400.00Current price is: ₹ 29,400.00.NOVARTIS
PACKING : 1X2ML
GENERIC NAME : OMALIZUMAB
-
-20%
Arbitus 250Mg Tab
Original price was: ₹ 39,500.00.₹ 31,600.00Current price is: ₹ 31,600.00.DR. REDDY’S LABORATARY
PACKING : 1X120
GENERIC NAME : ABIRATERONE ACETATE
-
-20%
Plegridy 125 Mcg/0.5Ml
Original price was: ₹ 40,684.00.₹ 32,550.00Current price is: ₹ 32,550.00.BIOGEN IDEC
PACKING : 2 PEN
GENERIC NAME : PEGINTERFERON ALFA 2A
-
-13%
Zytiga 250Mg Tab
Original price was: ₹ 150,000.00.₹ 130,000.00Current price is: ₹ 130,000.00.JOHNSON & JOHNSON LTD
PACKING : 1X120
GENERIC NAME : ABIRATERONE ACETATE
-
-11%
#Xtandi 40 Mg Soft Cap
Original price was: ₹ 335,635.00.₹ 300,000.00Current price is: ₹ 300,000.00.Generic name: enzalutamide
Dosage form: capsules (40mg), tablets (40mg, 80mg)
Drug classes: Antiandrogens, Hormones / antineoplasticsWhat is Xtandi?
- Xtandi is an androgen receptor inhibitor used to treat certain prostate cancers. It works by preventing the actions of androgens (male hormones) to help control cancer growth and decrease tumor size.
- Xtandi is prescribe when prostate cancer no longer responds to hormone therapy or surgical treatment. It is also used when prostate cancer has spread to other parts of the body and responds to hormone therapy or surgery to lower testosterone. Additionally, Xtandi is use in patients whose cancer has not spread but are at high risk of metastasis.
